Safety Documents
SDS + CRA
Safety Training
Blog
MANUFACTURERS
Organon & Co.
1265
REGULATIONS
GHS/CLP
897
OSHA
368
LANGUAGES
English
1265
SDS & CRA
‹‹
‹
68
69
70
71
72
›
››
Pancrelipase (High / Low Lipase) Formulation
Manufacturer:
Organon & Co.
Product Code:
5322086-00010
Revision:
2024-03-28, English, GHS/CLP
Download SDS
Download CRA
View Details
Add to Library
Pancrelipase (High / Low Lipase) Formulation
Manufacturer:
Organon & Co.
Product Code:
5322083-00011
Revision:
2024-03-28, English, GHS/CLP
Download SDS
Download CRA
View Details
Add to Library
Clindamycin Phosphate (2%) Vaginal Gel Formulation
Manufacturer:
Organon & Co.
Product Code:
n/a
Revision:
2023-10-11, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Mirtazapine Solid Formulation
Manufacturer:
Organon & Co.
Product Code:
51079-00021
Revision:
2023-09-30, English, GHS/CLP
Download SDS
Download CRA
View Details
Add to Library
Olmesartan / Hydrochlorothiazide Formulation
Manufacturer:
Organon & Co.
Product Code:
402634-00017
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Enalapril Formulation
Manufacturer:
Organon & Co.
Product Code:
734751-00016
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Infliximab Formulation - (Ogn)
Manufacturer:
Organon & Co.
Product Code:
n/a
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Felbamate Suspension Formulation
Manufacturer:
Organon & Co.
Product Code:
n/a
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Olmesartan Formulation
Manufacturer:
Organon & Co.
Product Code:
n/a
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
Betamethasone (0.05%) Cream Formulation
Manufacturer:
Organon & Co.
Product Code:
n/a
Revision:
2023-09-30, English, OSHA
Download SDS
Download CRA
View Details
Add to Library
‹‹
‹
68
69
70
71
72
›
››
Need help with Safety Data Sheets? You've come to the right place!
CONTACT US